Vaxart, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Vaxart, Inc. (VXRT) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $100.00 thousand for the 12-month period ending 2015-06-30, per its 10-K filed 2016-09-13.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2016-09-13
- Vaxart, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2015 was $100.00K, a 66.67% decline from fiscal 2014.
- Vaxart, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2014 was $300.00K, a 72.73% decline from fiscal 2013.
- Vaxart, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2013 was $1.10M, a 266.67% increase from fiscal 2012.
- Vaxart, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2012 was $300.00K, a 72.73% decline from fiscal 2011.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month |
|---|---|
| 2015-06-30 | $100.00K 10-K · filed 2016-09-13 |
| 2014-06-30 | $300.00K 10-K · filed 2016-09-13 |
| 2013-06-30 | $1.10M 10-K · filed 2015-09-11 |
| 2012-06-30 | $300.00K 10-K · filed 2014-09-30 |
| 2011-06-30 | $1.10M 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |